John Cox (Photo: Repligen)
The time is now: John Cox assumes CEO post at Flagship-backed Torque, steering cell therapy to clinical trials
A stealthy Torque Therapeutics is in the midst of raising a Series B round to bankroll an upcoming slate of clinical studies for its cancer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
